Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection

Simple item page
dc.contributor.authorColin Forsyth
dc.contributor.authorFacundo Garcia-Bournissen
dc.contributor.authorGuillermo Moscatelli
dc.contributor.authorSamanta Moroni
dc.contributor.authorAna Cristina Pereiro
dc.contributor.authorLourdes Ortiz-Daza
dc.contributor.authorElvira-Idalia Hernández Cuevas
dc.contributor.authorFreddy Tinajeros
dc.contributor.authorTayná Marques
dc.contributor.authorAndrea Marchiol
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:58:39Z
dc.date.available2026-03-22T19:58:39Z
dc.date.issued2026
dc.description.abstractThe TPP provides guidance for essential and ideal characteristics of formulations of new drugs for the treatment of children with T. cruzi infection.
dc.identifier.doi10.1371/journal.pntd.0013597
dc.identifier.urihttps://doi.org/10.1371/journal.pntd.0013597
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/79255
dc.language.isoen
dc.publisherPublic Library of Science
dc.relation.ispartofPLoS neglected tropical diseases
dc.sourceHospital General de Niños Ricardo Gutierrez
dc.subjectMedicine
dc.subjectChagas disease
dc.subjectIntensive care medicine
dc.subjectSafety profile
dc.subjectBiological drugs
dc.subjectDrug
dc.subjectImmunology
dc.subjectPharmacology
dc.subjectTrypanosoma cruzi
dc.subjectProduct (mathematics)
dc.titleTarget product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection
dc.typearticle

Files

Collections

Artículo Científico Publicado